Virtus Investment Advisers’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.83M Buy
8,056
+5,906
+275% +$2.11M 0.78% 2
2025
Q4
$704K Buy
2,150
+655
+44% +$208K 0.19% 163
2025
Q3
$422K Sell
1,495
-4,935
-77% -$1.43M 0.12% 221
2025
Q2
$1.8M Buy
6,430
+5,121
+391% +$1.45M 0.61% 21
2025
Q1
$408K Buy
+1,309
New +$387K 0.11% 208
2023
Q3
Sell
-420
Closed -$93.2K 246
2023
Q2
$93.2K Sell
420
-776
-65% -$180K 0.06% 246
2023
Q1
$289K Sell
1,196
-1,049
-47% -$258K 0.2% 142
2022
Q4
$590K Buy
2,245
+1,852
+471% +$496K 0.39% 72
2022
Q3
$89K Buy
+393
New +$95.3K 0.04% 309
2018
Q1
Sell
-3,070
Closed -$534K 33
2017
Q4
$534K Sell
3,070
-154
-5% -$27.3K 0.06% 286
2017
Q3
$601K Sell
3,224
-382
-11% -$67.7K 0.06% 286
2017
Q2
$621K Sell
3,606
-748
-17% -$122K 0.06% 293
2017
Q1
$714K Buy
+4,354
New +$723K 0.06% 287
2016
Q4
Sell
-15,973
Closed -$2.66M 471
2016
Q3
$2.66M Buy
+15,973
New +$2.7M 0.17% 184

Other funds holding AMGN

Virtus Investment Advisers's AMGN Position: Q1 2026 in Review

Virtus Investment Advisers increased its Amgen (AMGN) stake by 275% in Q1 2026, buying an estimated $2.11M and bringing the position to 8,056 shares worth $2.83M. The position accounts for 0.78% of the portfolio, ranked #2.

Virtus Investment Advisers first reported a position in AMGN in Q3 2016 and has held it in 14 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Virtus Investment Advisers held 8,056 shares of Amgen worth $2.83M as of Q1 2026.
  • Virtus Investment Advisers bought 5,906 Amgen shares in Q1 2026, an estimated $2.11M.
  • Amgen made up 0.78% of Virtus Investment Advisers's portfolio in Q1 2026, its #2 holding.
  • Virtus Investment Advisers first reported a position in Amgen in Q3 2016 and has held it in 14 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.